Camlin Fine Sciences Limited

Camlin Fine Sciences will hold an earnings call on May 26, 2026 to discuss Q4 and FY26 audited financial results. The call will feature Chairman & MD Ashish Dandekar, MD Nirmal Momaya, and CFO Santosh

• Camlin Fine Sciences board meeting scheduled for May 26, 2026, to approve Q4 and FY26 audited financial results. • Trading window for company equity shares closed from April 1, 2026, until 48 hours